Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Solovic

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|September 26, 2014
Classical against molecular-genetic methods for susceptibility testing of antituberculoticsI Porvaznik, J Mokry, I Solovic
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|June 8, 2019
Detection of resistance to anti-tuberculosis drugs in the clinical isolates of Mycobacterium tuberculosis from Slovakia through comparison between phenotypic and genetic methods and evaluation of resistance levels with clinical parameterJ Mokry, I Porvaznik, P Kusnir, et al.
Bratislavske Lekarske Listy|September 26, 2008
The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitorsI Rybar, E Rozborilova, E Zanova, et al.
Pulmonology|January 3, 2018
Migration, TB control and elimination: Whom to screen and treatA Rendon, R Centis, J-P Zellweger, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 6, 2013
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011I Solovic, J Jonsson, M Korzeniewska-Koseła, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 5, 2023
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settingsL Saderi, A M Cabibbe, M Puci, et al.
The European Respiratory Journal|May 2, 2009
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementU Mack, G B Migliori, M Sester, et al.
Pulmonology|September 7, 2023
Vaccination in post-tuberculosis lung disease management: A review of the evidenceM J Nasiri, D R Silva, F Rommasi, et al.
The European Respiratory Journal|June 10, 2010
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statementI Solovic, M Sester, J J Gomez-Reino, et al.
IJTLD Open|February 17, 2025
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in EuropeO Kirakosyan, M Reimann, A B Andersen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|September 26, 2014
Classical against molecular-genetic methods for susceptibility testing of antituberculoticsI Porvaznik, J Mokry, I Solovic
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|June 8, 2019
Detection of resistance to anti-tuberculosis drugs in the clinical isolates of Mycobacterium tuberculosis from Slovakia through comparison between phenotypic and genetic methods and evaluation of resistance levels with clinical parameterJ Mokry, I Porvaznik, P Kusnir, et al.
Bratislavske Lekarske Listy|September 26, 2008
The effectiveness for prevention of tuberculosis in patients with inflammatory rheumatic diseases treated with TNF inhibitorsI Rybar, E Rozborilova, E Zanova, et al.
Pulmonology|January 3, 2018
Migration, TB control and elimination: Whom to screen and treatA Rendon, R Centis, J-P Zellweger, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 6, 2013
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011I Solovic, J Jonsson, M Korzeniewska-Koseła, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 5, 2023
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settingsL Saderi, A M Cabibbe, M Puci, et al.
The European Respiratory Journal|May 2, 2009
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementU Mack, G B Migliori, M Sester, et al.
Pulmonology|September 7, 2023
Vaccination in post-tuberculosis lung disease management: A review of the evidenceM J Nasiri, D R Silva, F Rommasi, et al.
The European Respiratory Journal|June 10, 2010
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statementI Solovic, M Sester, J J Gomez-Reino, et al.
IJTLD Open|February 17, 2025
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in EuropeO Kirakosyan, M Reimann, A B Andersen, et al.
Pageof 2